Niramai in News

Niramai Health Analytix Selected for MedTech Innovator Asia Pacific 2024 Accelerator Cohort

Niramai Health Analytix is proud to announce its selection for the MedTech Innovator Asia Pacific 2024 Accelerator Cohort Program, the world’s largest accelerator for medical technology companies. This year, 20 companies were chosen from over 400 applicants after a rigorous selection process.

MedTech Innovator, in partnership with the Asia Pacific Medical Technology Association (APACMed), connects top startups with investors, business leaders, and professionals to drive the commercialization of life-changing technologies.

“Niramai Health Analytix’s inclusion in this program is a significant milestone,” said Dr. Geetha Manjunath, Founder and CEO. “Our AI-based breast cancer screening solution can revolutionize early detection and improve patient outcomes.”

The cohort program, held from June 12 to 14 in Mountain View, California, was attended by Dr. Manjunath, who engaged with other innovators and industry leaders.

“We are delighted to announce this year’s cohort, representing a broad range of technologies and innovations,” said Fredrik Nyberg, Managing Director, MedTech Innovator Asia Pacific. “We look forward to supporting them in advancing their technologies and transforming patient lives globally.”

Read More

Niramai Health Analytix & Aktion Pink unite to combat breast cancer

NIRAMAI Health Analytix, an innovative health tech startup based out of India, dedicated to early detection of breast cancer, proudly announces its collaboration with Action Pink, a renowned NGO based in Germany. This partnership marks a significant milestone in the global fight against breast cancer.

NIRAMAI, established in 2016, has pioneered a novel radiation-free screening test that is revolutionizing breast cancer screening with its innovative Artificial Intelligence-based technique called Thermalytix®. The mission of NIRAMAI is to enable non-invasive technology enabled solutions for early detection of cancer. Thermalytix is a portable screening test which ensures patient privacy and also offers a painless experience with accurate results. 

Aktion Pink, established in 1999, has been instrumental in raising awareness about breast cancer and advocating for early detection strategies. Led by CEO Corinna Saric, Action Pink empowers individuals with knowledge and resources to combat breast cancer effectively.

The collaboration between NIRAMAI Health Analytix and Action Pink significantly unites efforts to combat breast cancer globally. By combining innovative technology with advocacy and awareness initiatives, the partnership aims to enhance early detection rates and improve outcomes for individuals affected by breast cancer.

“We are thrilled to join forces with Action Pink with our shared mission to create a life-saving impact through awareness creation and early detection of cancer. ” says Dr. Geetha Manjunath, CEO of NIRAMAI Health Analytix.  

“We believe that by working together, we can make a meaningful impact in the fight against breast cancer,” adds Corinna Saric, CEO of Action Pink.




Read More

President of India Interacts With Leading Women Start-ups & Unicorns

The President of India, Smt Droupadi Murmu interacted with a group of women who are founders and co-founders of leading start-ups and unicorns at Rashtrapati Bhavan.
This meeting took place under the initiative “The President with the People” which aims to establish a deeper connect with people and recognise their contributions.
Read more:https://pib.gov.in/PressReleasePage.aspx?PRID=1997259

Read More